John Chiang - 19 Nov 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
19 Nov 2024
Transactions value $
$18
Form type
4
Filing time
20 Nov 2024, 16:16:15 UTC
Previous filing
25 Nov 2024
Next filing
13 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $27,891 +1,515 +9.56% $18.41 17,364 19 Nov 2024 Direct
transaction ASTH Common Stock Tax liability -$27,873 -681 -3.92% $40.93 16,683 19 Nov 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -1,515 -100% $0.000000 0 19 Nov 2024 Common Stock 1,515 $18.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were fully vested and exercisable.
F2 Includes 4,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.